| 000 | 01701 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250514182346.0 | ||
| 264 | 0 | _c20040728 | |
| 008 | 200407s 0 0 eng d | ||
| 022 | _a0378-5173 | ||
| 024 | 7 |
_a10.1016/j.ijpharm.2003.11.036 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKofuji, K | |
| 245 | 0 | 0 |
_aTherapeutic efficacy of sustained drug release from chitosan gel on local inflammation. _h[electronic resource] |
| 260 |
_bInternational journal of pharmaceutics _cMar 2004 |
||
| 300 |
_a65-78 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdjuvants, Pharmaceutic _xchemistry |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xpharmacokinetics |
| 650 | 0 | 4 |
_aCapillary Permeability _xdrug effects |
| 650 | 0 | 4 | _aCarrageenan |
| 650 | 0 | 4 |
_aChitin _xanalogs & derivatives |
| 650 | 0 | 4 | _aChitosan |
| 650 | 0 | 4 | _aDelayed-Action Preparations |
| 650 | 0 | 4 | _aDrug Carriers |
| 650 | 0 | 4 | _aDrug Compounding |
| 650 | 0 | 4 | _aGels |
| 650 | 0 | 4 |
_aInflammation _xchemically induced |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred Strains |
| 650 | 0 | 4 |
_aPrednisolone _xpharmacokinetics |
| 650 | 0 | 4 |
_aSkin _xmetabolism |
| 650 | 0 | 4 | _aSolubility |
| 700 | 1 | _aAkamine, H | |
| 700 | 1 | _aQian, C J | |
| 700 | 1 | _aWatanabe, K | |
| 700 | 1 | _aTogan, Y | |
| 700 | 1 | _aNishimura, M | |
| 700 | 1 | _aSugiyama, I | |
| 700 | 1 | _aMurata, Y | |
| 700 | 1 | _aKawashima, S | |
| 773 | 0 |
_tInternational journal of pharmaceutics _gvol. 272 _gno. 1-2 _gp. 65-78 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ijpharm.2003.11.036 _zAvailable from publisher's website |
| 999 |
_c14738487 _d14738487 |
||